Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0POVEN
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Cetuximab-I-39-0.46
|
|||||
| Synonyms |
Cetuximab-I-39-0.46
Click to Show/Hide
|
|||||
| Organization |
Kleo Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
0.46
|
|||||
| Structure |
|
|||||
| Antibody Name |
Cetuximab
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
Cetuximab-I-45-0.7 payload
|
Payload Info | ||||
| Linker Name |
Cetuximab-I-39-0.46 linker
|
Linker Info | ||||
| Conjugate Type |
site-specific conjugation
|
|||||
| Combination Type |
I-39
|
|||||